Home | Life Sciences Intellectual Property Review
4 days ago · 23 January 2025 Teva insisted panel’s narrow interpretation of ‘claims the drug’ will have a seismic effect on the Orange Book | Stay granted while en banc rehearing is under …
Latest News & Features | Life Sciences Intellectual Property Review
Jan 28, 2025 · Complex legal battle concerns ‘skinny label’ strategy used by generic drug makers, prompting a $235 million award | Pharma giant looks for enhanced damages due to ‘wilful …
Americas | Life Sciences Intellectual Property Review
14 November 2024 Transatlantic deal would make ‘HSF Kramer’ a top 20 global firm by revenue | ‘Transformational’ combination a ‘one-of-a-kind’ opportunity, say firms’ leaders | HSF Kramer …
New national rankings recognise top US patent firms and lawyers
3 days ago · LSIPR sister title releases USA Patents Rankings, divided into categories of non-contentious and contentious work | Listing identifies the go-to firms and individuals for …
Regeneron holds off copies of $6bn eye treatment
3 days ago · 29 August 2024 Regeneron accused the Swiss pharma company of infringing a slew of patents related to Eylea and violating the BPCIA | Suit alleges that Sandoz failed to provide …
Fed Circ raises ‘gamesmanship’ fears in rare patent term dispute
1 day ago · Oral hearings heard the USPTO side with MSD (Merck) over a term extension for a reissued patent, in a case set to have huge implications for pharma market exclusivity, reports …
ADCs, TCR, and multimodal AI: Transformative trends in 2025
Jan 23, 2025 · For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at …
Conference Videos | Life Sciences Intellectual Property Review
Jan 27, 2025 · LSPN Fall 2024 took place on October 15-16 in San Francisco, gathering an unrivalled assembly of in-house patent counsel, intellectual property professionals, and …
About | Life Sciences Intellectual Property Review
About. Life Sciences Intellectual Property Review tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences.From gene patents to stem …
‘This is a big problem’: The CRISPR controversy and the ‘mess’ at …
Sep 27, 2024 · A request by CRISPR scientists to withdraw their patents over allegations of mishandling by the EPO’s Boards of Appeals has thrust a ‘fundamentally unfair, uncertain …